definiens: shall mean the Initial Clinical Candidate and ( i ) those other individual Compoundsselected as a Selected Compound by the JSC under Section 5.2, ( ii ) those Compounds that are Selected Compoundsunder Section 5.3.1(b ), ( iii ) Compounds for which an Additional Partner or Third Party has rights to develop, market orcommercialize as described in Section 5.3.5, and ( iv ) all [COMPANY] Reserve Compounds in compliance withSection 5.3.1(a ) below . With respect to each such Compound, the Selected Compound shall include prodrugs, metabolites, salts, esters, hydrates, solvates, free base, polymorphs, isomers thereof, conjugated forms and / orliposomal or other formulations thereof and other compositions consisting of such Compound non - covalently bondedwith other moieties, which together shall be deemed a single Selected Compound ( and a single [COMPANY] ReserveCompound ) for purposes of Sections 5.2, 5.3.1(a)(ii ) and 5.3.1(b ) below